Immunohistochemical analysis is therefore critical to distinguish metastatic breast carcinoma from lung adenocarcinoma; markers such as ER, PR, and GATA3 support a breast origin, whereas TTF-1 and napsin A favor lung adenocarcinoma [9]. This evidence concerns the gene NAPSA and lung adenocarcinoma.